Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: E9AT82
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.518 |
CLV_PCSK_FUR_1 | 91 | 95 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.466 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.457 |
CLV_PCSK_PC7_1 | 91 | 97 | PF00082 | 0.461 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.359 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.454 |
DOC_MAPK_gen_1 | 71 | 79 | PF00069 | 0.424 |
DOC_MAPK_MEF2A_6 | 71 | 79 | PF00069 | 0.409 |
LIG_14-3-3_CanoR_1 | 76 | 80 | PF00244 | 0.376 |
LIG_APCC_ABBA_1 | 77 | 82 | PF00400 | 0.392 |
LIG_APCC_ABBAyCdc20_2 | 76 | 82 | PF00400 | 0.395 |
LIG_LIR_Gen_1 | 20 | 29 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 20 | 26 | PF02991 | 0.418 |
LIG_MAD2 | 5 | 13 | PF02301 | 0.284 |
LIG_SH2_CRK | 29 | 33 | PF00017 | 0.430 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.508 |
LIG_SUMO_SIM_anti_2 | 3 | 10 | PF11976 | 0.377 |
LIG_SUMO_SIM_par_1 | 3 | 10 | PF11976 | 0.377 |
LIG_SxIP_EBH_1 | 5 | 18 | PF03271 | 0.284 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.499 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.541 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.460 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.284 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.284 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.377 |
MOD_NEK2_2 | 21 | 26 | PF00069 | 0.508 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.375 |
MOD_Plk_4 | 21 | 27 | PF00069 | 0.508 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.375 |
MOD_SUMO_rev_2 | 81 | 89 | PF00179 | 0.512 |
TRG_DiLeu_BaEn_1 | 4 | 9 | PF01217 | 0.367 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.430 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.430 |
TRG_ER_diArg_1 | 91 | 94 | PF00400 | 0.463 |
TRG_NLS_MonoCore_2 | 91 | 96 | PF00514 | 0.462 |
TRG_NLS_MonoExtC_3 | 91 | 96 | PF00514 | 0.462 |
TRG_NLS_MonoExtN_4 | 91 | 96 | PF00514 | 0.462 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P798 | Leptomonas seymouri | 90% | 98% |
A0A1X0NKC5 | Trypanosomatidae | 66% | 100% |
A0A3R7KER9 | Trypanosoma rangeli | 69% | 100% |
A4HPH0 | Leishmania braziliensis | 96% | 100% |
D0A3I0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 79% |
O59670 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 42% | 100% |
P59708 | Mus musculus | 36% | 94% |
Q8ITY4 | Caenorhabditis elegans | 35% | 86% |
Q9FMP4 | Arabidopsis thaliana | 40% | 95% |
Q9VRV7 | Drosophila melanogaster | 36% | 98% |
Q9Y3B4 | Homo sapiens | 36% | 94% |
V5BFU0 | Trypanosoma cruzi | 70% | 100% |